ClinicalTrials.Veeva

Menu

Inflammatory Marker in Ibd and Peripheral Arthritis

A

Assiut University

Status

Not yet enrolling

Conditions

IBD-Inflammatory Bowel Disease

Study type

Observational

Funder types

Other

Identifiers

NCT05705232
IBD and peripheral arthritis

Details and patient eligibility

About

The Objective Of This Study Is To Estimate The Correlation Between Disease Activity In IBD, Inflammatory Markers And Peripheral Arthritis After Exclusion Of Other Causes Arthritis

Full description

Inflammatory Bowel Diseases (IBD) Are Chronic Relapsing Inflammatory Disorder Of The Gastrointestinal Tract (GIT) , Which Represented Mainly By Ulcerative Colitis (UC) And Crohn's Disease .

IBD Is To Be Considered Systemic Disease Since They Are Often Associated With Extra intestinal Manifestation, Especially During Activity, Which Reflect A Pathogenic Mechanism As Arthritis ,Erythema Nodosum ,Pyoderma Gangrenosum , Apthous Ulceration ,Iritis And Uveitis.

Peripheral Arthritis (Pa) Is Observed Rather Than Frequently, The Arthritis Involves Predominantly The Joint Of The Lower Limb ,And In Most Cases It Accompanies The Activity Of The Intestinal Disease Pauciarticular, Asymmetric, Migratory And Non Deforming.

Predicting Relapse By Measuring Non Invasive Biomarkers Could Allow Early Treatment Adaptation .Several Studies Have Shown A Correlation Between Intestinal Inflammation And Serum C-Reactive Protein Or Fecal Calprotectin Levels .

Enrollment

150 estimated patients

Sex

All

Ages

16 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • 1-Pt Above 18 Yrs. 2- IBD Pt. Confirmed By Colonoscopy 3- IBD Patient with Arthritis During Activity

Exclusion criteria

  • 1-Age Below 18 Yrs. Old 2-Arthritis Of Other Causes Than IBD PT

Trial contacts and locations

0

Loading...

Central trial contact

Mostafa Mansor; Nabila Fayek

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems